Bangkok, BOI announced approval to promote investment in BBGI Firmbox Bio Company Limited, a joint venture between BBGI and Fermbox Bio from India, in a project to produce enzymes for industry, developed from Lab-Scale. To Commercial-Scale The first large scale in the ASEAN region Help raise the level of the country's BCG upstream industry. Mr. Narit Therdsatheerasak Secretary-General of the Board of Investment (BOI) revealed that the BOI has approved investment promotion for BBGI Firmbox Bio Company Limited, which is a joint venture between BBGI Public Company Limited. ) in Bangchak Group Leader in high value biological products business with Firmbox Bio Company, India who is an expert in synthetic biology (Synbio) and in expanding production capacity to commercial production (Lab-to-launch) to establish a biotechnology factory that uses Precision Fermentation technology to produce Cellulosic Enzyme. For use in industry By expanding the scale from the laboratory and pilot plant level to the commercial lev el. This is considered the first large-scale advanced biotechnology factory in the ASEAN region. With an initial production capacity of 200,000 liters, consisting of two large 100,000 liter fermentation tanks, the company aims to increase the total production capacity to 1 million liters in the next phase, with an initial investment of 440 million baht. Located in Chachoengsao Province and will use most of the raw materials from within the country Cellulosic Enzyme is an enzyme that helps digest and convert cellulose in biomass waste such as wood chips, rice straw, cassava waste and bagasse into glucose. which can be extended to produce a variety of biological products such as bioplastics, biochemicals, bioproteins, biofuel jet fuel (SAF), etc. The company also has plans to expand production to other synthetic biology products (Synbio) for use in the food and health supplement industry. Cosmeceuticals and energy in the next phase as well. In addition, the company has prepared a memorandum of understanding ( MOU) to establish cooperation with the Biotechnology and Genetic Engineering Research Institute. Chulalongkorn University In transferring technology to scale up production in biological processes from the laboratory and pilot plant levels to the commercial level to the institute's researchers as well. 'This decision to invest in setting up an advanced biotechnology factory that is the first large-scale commercial production in ASEAN. It reinforces Thailand's potential in biodiversity. including the readiness of raw materials infrastructure and personnel. This project will help upgrade the upstream industry in biotechnology. Continuing with research to be able to scale up to the industrial level. It also plays an important role in driving the economic model. Bio-Circular-Green or BCG to aim to be a Bio Hub of the ASEAN region,' Mr. Narit said. Source: Thai News Agency